AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimsafe MF 2mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Beats Pharmaceuticals

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimsafe MF 2mg/500mg Tablet

DiabetaComb 2mg/500mg tablets are classified as antidiabetic medications, combining two drugs to manage type 2 diabetes in adults. This treatment helps regulate blood sugar. DiabetaComb 2mg/500mg tablets should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may adjust based on your blood glucose response. Continue this medication even with controlled blood sugar; abrupt cessation, without physician consultation, risks elevated blood sugar, potentially leading to kidney complications, vision loss, nerve damage, and limb loss. Remember, this medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headache, and trembling. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are crucial. Alcohol should be avoided due to its hypoglycemic risk. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver disease. Prior heart disease should be disclosed to your doctor before commencing treatment. Pregnant or breastfeeding individuals require physician consultation prior to use. Regular blood sugar monitoring and potential blood tests (blood cell counts, liver function) may be recommended by your physician.

Uses of Glimsafe MF 2mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Glimsafe MF 2mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimsafe MF 2mg/500mg Tablet whole; avoid chewing, crushing, or breaking it. Administer this medicine with a meal.

Common Side effects of Glimsafe MF 2mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimsafe MF 2mg/500mg Tablet:

Consume Glimsafe MF 2mg/500mg tablets as directed by your physician, following the prescribed dosage and schedule. Ingest the tablets whole; avoid crushing, chewing, or breaking them. Administer this medication with a meal.

How Glimsafe MF 2mg/500mg Tablet works:

Each Glimsafe MF 2mg/500mg tablet combines glimepiride (a sulfonylurea) and metformin (a biguanide), both acting to manage blood sugar. Glimepiride stimulates the pancreas to release more insulin, thus reducing blood glucose. Metformin's action is threefold: it decreases liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Glimsafe MF 2mg/500mg Tablet is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimsafe MF 2mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Medical advice is recommended.

Breast feedingBreast feedingUNSAFE

Maternal use of Glimsafe MF 2mg/500mg tablets while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimsafe MF 2mg/500mg tablets cautiously, potentially requiring dosage modification. Physician consultation is essential. The medication is contraindicated in patients with severe kidney disease. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Individuals with liver impairment should use Glimsafe MF 2mg/500mg tablets cautiously. Dosage modification may be necessary; physician consultation is advised. For patients with mild to moderate liver disease, initiation with a low dose is typical; however, its use is contraindicated in those with severe hepatic dysfunction.

What if you forget to take Glimsafe MF 2mg/500mg Tablet :

Should you forget to take a Glimsafe MF 2mg/500mg Tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosage regimen. Avoid taking a double dose.

Facts to Know About Glimsafe MF 2mg/500mg Tablet

LabelValue
Potential for Dependence None.
Type of Medication Medication for diabetes

FAQs on Glimsafe MF 2mg/500mg Tablet

Maintain this medication within its original, sealed container. Follow the storage guidelines provided on the packaging. Discard any remaining medication. Prevent accidental ingestion by children, pets, and others.
Lactic acidosis, a serious medical condition characterized by excessive blood lactic acid, is a potential consequence of taking Glimsafe MF 2mg/500mg Tablets. This complication, also termed Metformin-associated lactic acidosis (MALA), is infrequent but poses a significant risk to individuals with impaired kidney function, the elderly, and heavy alcohol consumers. Symptoms may manifest as muscle aches or weakness, lightheadedness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal discomfort, or bradycardia. Should any of these symptoms appear, discontinue Glimsafe MF 2mg/500mg Tablet use and seek immediate medical attention.
Glimepiride and Metformin, combined as Glimsafe MF 2mg/500mg Tablet, manage type 2 diabetes mellitus (DM) in adults. This dual-action therapy enhances blood sugar control when coupled with a balanced diet and exercise regimen. Glimepiride stimulates insulin secretion from the pancreas, reducing blood glucose. Concurrently, Metformin diminishes hepatic glucose production and augments insulin responsiveness. This formulation is unsuitable for type 1 DM.
Glimsafe MF 2mg/500mg Tablets may cause common adverse reactions including hypoglycemia, taste disturbances, nausea, abdominal discomfort, diarrhea, and headache. Rare but potentially serious side effects such as lactic acidosis may also occur. Prolonged treatment may result in vitamin B12 deficiency.
Prolonged Glimsafe MF 2mg/500mg Tablet consumption can indeed lead to Vitamin B12 deficiency due to impaired intestinal Vitamin B12 absorption. This deficiency, if left unaddressed, may result in anemia, neurological complications such as peripheral neuropathy (manifesting as tingling, numbness in extremities, and weakness), urinary dysfunction, cognitive changes, and gait instability (ataxia). Preventive measures suggested by some studies include annual supplemental Vitamin B12 intake.
Indeed, Glimsafe MF 2mg/500mg Tablets may induce hypoglycemia (low blood glucose). Manifestations of low blood sugar encompass nausea, headache, irritability, hunger pangs, sweating, dizziness, tachycardia, and feelings of anxiety or tremor. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Carrying a readily available fast-acting carbohydrate source, such as glucose tablets, honey, or fruit juice, is recommended.
Combining Glimsafe MF 2mg/500mg tablets and alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and raises the risk of lactic acidosis.
Glimsafe MF 2mg/500mg Tab...
49
MRP 60
18% off